LBO France, the Paris-based buyout group, has appointed Vincent Briançon as director for its White Knight Funds.
He will join LBO France from London-headquartered Bridgepoint, where he spent the last 14 years of his career. Having started in the firm’s London offices, he then moved to Paris in 2000 and was promoted partner in 2008. He was previously an analyst in the London M&A department of Société Générale.
The 40-year-old Frenchman brings with him solid experience in healthcare and consumer good transactions, said LBO France in a statement. He was involved in eight closings during his tenure at Bridgepoint, including Medica, Medipole, Nocibé, Alain Afflelou and Histoire d’Or, and sat on the board of several of the firm’s portfolio companies.
His appointment comes as LBO France has yet to announce a launch date for its White Knight Fund IX. The firm was planning to start fundraising in the first quarter of last year, but turbulent economic conditions and uncertainty over the outcome of last year’s French presidential elections led it to delay the launch, Private Equity International reported at the time. White Knight VIII, the latest of the series, is now fully invested.
The firm also raised its second debt vehicle last year. The fund, Altercap II, reached its €200 million hard-cap a few weeks after the White Knight announcement.